Palmitate and Stearate are Increased in the Plasma in a 6-OHDA Model of Parkinson’s Disease
Anuri Shah(King's College London), Cristina Legido‐Quigley(Steno Diabetes Centers)
Cited by 29
Related Papers
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
|PLoS Medicine|2018|496
Metabolic network failures in Alzheimer's disease: A biochemical road map
|Alzheimer s & Dementia|2017|492
A top‐down systems biology view of microbiome‐mammalian metabolic interactions in a mouse model
|Molecular Systems Biology|2007|471
Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease
|Journal of Hepatology|2021|141
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2023|74